{
    "eid": "2-s2.0-85107346642",
    "title": "Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma",
    "cover-date": "2021-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Thanpisit Lomphithak",
        "Perawatt Akara-amornthum",
        "Keigo Murakami",
        "Masatoshi Hashimoto",
        "Hajime Usubuchi",
        "Erina Iwabuchi",
        "Michiaki Unno",
        "Zhenyu Cai",
        "Hironobu Sasano",
        "Siriporn Jitkaew"
    ],
    "citedby-count": 15,
    "ref-count": 70,
    "ref-list": [
        "Expert consensus document: Cholangiocarcinoma: Current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)",
        "Cholangiocarcinoma\u2014Evolving concepts and therapeutic strategies",
        "Innate and adaptive immune cells in the tumor microenvironment",
        "Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer",
        "Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma",
        "Immunotherapy of biliary tract cancer",
        "Identification of four immune subtypes characterized by distinct composition and functions of tumor microenvironment in intrahepatic cholangiocarcinoma",
        "Necroptosis",
        "Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase",
        "Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis",
        "Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis",
        "Necroptosis: the release of damage-associated molecular patterns and its physiological relevance",
        "RIPK1 and NF-\u03baB signaling in dying cells determines cross-priming of CD8+ T cells",
        "Vaccination with necroptotic cancer cells induces efficient anti-tumor immunity",
        "Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes",
        "Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity",
        "RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function",
        "Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis",
        "Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis",
        "The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression",
        "Necroptosis microenvironment directs lineage commitment in liver cancer",
        "Necroptosis regulates tumor repopulation after radiotherapy via RIP1/RIP3/MLKL/JNK/IL8 pathway",
        "Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis",
        "Receptor-interacting protein kinase 3 is a predictor of survival and plays a tumor suppressive role in colorectal cancer",
        "Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-alpha and chemotherapeutic gemcitabine-induced necroptosis",
        "MLKL attenuates colon inflammation and colitis-tumorigenesis via suppression of inflammatory responses",
        "The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy",
        "De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors",
        "Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression",
        "Mechanisms regulating PD-L1 expression on tumor and immune cells",
        "Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy",
        "Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer",
        "Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma",
        "Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner",
        "Association of mixed lineage kinase domain-like protein expression with prognosis in patients with colon cancer",
        "Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients",
        "Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancer",
        "Prognostic and clinicopathological significance of MLKL expression in cancer patients: A meta-analysis",
        "Necroptosis, in vivo detection in experimental disease models",
        "Key roles of necroptotic factors in promoting tumor growth",
        "Effects of neoadjuvant FOLFIRONOX and gemcitabine-based chemotherapy on cancer cell survival and death in patients with pancreatic ductal adenocarcinoma",
        "Necroptosis is associated with a better survival in intrahepatic cholangiocarcinoma",
        "Necroptosis in cholangiocarcinoma",
        "MLKL, the protein that mediates necroptosis, also regulates endosomal trafficking and extracellular vesicle generation",
        "Reduction in MLKL-mediated endosomal trafficking enhances the TRAIL-DR4/5 signal to increase cancer cell death",
        "A necroptotic-independent function of MLKL in regulating endothelial cell adhesion molecule expression",
        "MLKL: Functions beyond serving as the executioner of necroptosis",
        "Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma",
        "Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma",
        "Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinoma",
        "Prognostic value of tumor-infiltrating FoxP3+ T cells in gastrointestinal cancers: A meta analysis",
        "Expression of Foxp3 and its prognostic significance in colorectal cancer",
        "Correction: Intratumoural-infiltrating CD4+ and FOXP3+ T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer",
        "CD45RA-Foxp3high but not CD45RA+Foxp3low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression",
        "Comparing the effects of different cell death programs in tumor progression and immunotherapy",
        "Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy",
        "PD-L1 (B7\u2013H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations",
        "Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway",
        "The clinicopathological and prognostic value of PD-L1 expression in cholangiocarcinoma: A meta-analysis",
        "Programmed death ligand 1 expression in human intrahepatic cholangiocarcinoma and its association with prognosis and CD8+ T-cell immune responses",
        "PD-L1 expression in extrahepatic cholangiocarcinoma",
        "PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma",
        "Program death 1 immune checkpoint and tumor microenvironment: Implications for patients with intrahepatic cholangiocarcinoma",
        "PD-L1 and HLA class I antigen expression and clinical course of the disease in intrahepatic cholangiocarcinoma",
        "Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma",
        "Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response",
        "Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer",
        "Prolonged response to anti-PD-1 antibody therapy in chemotherapy-refractory cholangiocarcinoma with high tumor mutational burden",
        "Elements of cancer immunity and the cancer\u2013immune set point",
        "Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Sendai",
            "@id": "60016416",
            "affilname": "Tohoku University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016416",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60129180",
            "affilname": "Tongji University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60129180",
            "affiliation-country": "China"
        }
    ],
    "funding": [
        "Faculty of Allied Health Sciences Research Fund",
        "Second Century Fund",
        "Office of the Higher Education Commission",
        "Chulalongkorn University",
        "Thailand Research Fund"
    ]
}